Gregory S. Bailey
Recent News About Gregory S. Bailey View More
-
Federal judge will allow consumer fraud claim to continue vs Pfizer over Robitussin labeling
A federal judge has again rejected pharmaceutical maker Pfizer’s request to end a potential consumer fraud class action over the labeling of its Robitussin Maximum Strength cough and cold medicine. -
Judge: Difference between 'mass action,' 'class action' means Pfizer can't flush Robitussin suit
A federal judge has rejected Pfizer’s attempt to scuttle a class action accusing the drugmaker of misleading consumers over the actual strength of its maximum strength Robitussin cough syrup, saying a U.S. Supreme Court decision doesn’t necessarily mean the company shouldn’t have to face a nationwide class action in Chicago federal court.